Par-4 binds to topoisomerase 1 and attenuates its DNA relaxation activity

被引:23
作者
Goswami, Anindya [1 ]
Qiu, Shirley [1 ]
Dexheimer, Thomas S. [3 ]
Ranganathan, Padhma [2 ]
Burikhanovl, Ravshan [1 ]
Pommier, Yves [3 ]
Rangnekar, Vivek M. [1 ,2 ,4 ,5 ]
机构
[1] Univ Kentucky, Dept Radiat Med, Lexington, KY 40536 USA
[2] Univ Kentucky, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40536 USA
[3] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA
[4] Univ Kentucky, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA
[5] NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1158/0008-5472.CAN-08-0831
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The regulation of DNA relaxation by topoisomerase 1 (TOP1) is essential for DNA replication, transcription, and recombination events. TOPI activity is elevated in cancer cells, yet the regulatory mechanism restraining its activity is not understood. We present evidence that the tumor suppressor protein prostate apoptosis response-4 (Par-4) directly binds to TOPI and attenuates its DNA relaxation activity. Unlike camptothecin, which binds at the TOPI-DNA interface to form cleavage complexes, Par-4 interacts with TOPI via its leucine zipper domain and sequesters TOPI from the DNA. Par-4 knockdown by RNA interference enhances DNA relaxation and gene transcription activities and promotes cellular transformation in a TOPI-dependent manner. Conversely, attenuation of TOPI activity either by RNA interference or Par-4 overexpression impedes DNA relaxation, cell cycle progression, and gene transcription activities and inhibits transformation. Colleclively, our findings suggest that Par-4 serves as an intracellular repressor of TOPI catalytic activity and regulates DNA topology to suppress cellular transformation.
引用
收藏
页码:6190 / 6198
页数:9
相关论文
共 46 条
  • [1] Boghaert ER, 1997, CELL GROWTH DIFFER, V8, P881
  • [2] NKX3.1 homeodomain protein binds to topoisomerase I and enhances its activity
    Bowen, Cai
    Stuart, August
    Ju, Jeong-Ho
    Tuan, Jenny
    Blonder, Josip
    Conrads, Thomas P.
    Veenstra, Timothy D.
    Gelmann, Edward P.
    [J]. CANCER RESEARCH, 2007, 67 (02) : 455 - 464
  • [3] Chakraborty M, 2001, CANCER RES, V61, P7255
  • [4] DNA topoisomerases: Structure, function, and mechanism
    Champoux, JJ
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 2001, 70 : 369 - 413
  • [5] Par-4 transcriptionally regulates bcl-2 through a WT1-binding site on the bcl-2 promoter
    Cheema, SK
    Mishra, SK
    Rangnekar, VM
    Tari, AM
    Kumar, R
    Lopez-Berestein, G
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (22) : 19995 - 20005
  • [6] The N-terminal domain anchors human topoisomerase I at fibrillar centers of nucleoli and nucleolar organizer regions of mitotic chromosomes
    Christensen, MO
    Barthelmes, HU
    Boege, F
    Mielke, C
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (39) : 35932 - 35938
  • [7] Decreased expression of the pro-apoptotic protein Par-4 in renal cell carcinoma
    Cook, J
    Krishnan, S
    Ananth, S
    Sells, SF
    Shi, Y
    Walther, MM
    Linehan, WM
    Sukhatme, VP
    Weinstein, MH
    Rangnekar, VM
    [J]. ONCOGENE, 1999, 18 (05) : 1205 - 1208
  • [8] Inactivation of the inhibitory κB protein kinase nuclear factor κB pathway by Par-4 expression potentiates tumor necrosis factor α-induced apoptosis
    Diaz-Meco, MT
    Lallena, MJ
    Monjas, A
    Frutos, S
    Moscat, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (28) : 19606 - 19612
  • [9] The product of par-4, a gene induced during apoptosis, interacts selectively with the atypical isoforms of protein kinase C
    DiazMeco, MT
    Municio, MM
    Frutos, S
    Sanchez, P
    Lozano, J
    Sanz, L
    Moscat, J
    [J]. CELL, 1996, 86 (05) : 777 - 786
  • [10] Identification of a unique core domain of par-4 sufficient for selective apoptosis induction in cancer cells
    El-Guendy, N
    Zhao, YM
    Gurumurthy, S
    Burikhanov, R
    Rangnekar, VM
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (16) : 5516 - 5525